“I think on a year-on-year basis there will be multiple jumps on profit because of the low base last year, which was, in turn, caused by a one-off expense last year. But on a quarterly basis, the third-quarter profit will probably be lower than the second quarter due to decline in income and some jump
0 Comments
He may be one of Wall Street’s biggest bears, but that doesn’t mean veteran market watcher David Rosenberg isn’t finding places to put money to work. Gluskin Sheff’s chief economist and strategist is just going halfway around the globe to do it. “The one part of the world which looks very good to me right
0 Comments
CNBC’s Jim Cramer was blown away by the hugely positive earnings reports from the market’s top technology companies that tricked in after Thursday’s bell. “Who did the best job? Who stole the show? Was it Amazon? Was it Alphabet? Maybe Intel. Could be Microsoft. The answer? All of them, and all for different reasons,” the
0 Comments
More than 90 funds focused on digital assets like bitcoin have launched this year, bringing the total number of such “crypto-funds” to 124, according to financial research firm Autonomous Next. Data shared exclusively with CNBC Friday showed that the largest share of the funds, 37 percent, used venture capitalist-type strategies and had about $1.1 billion
0 Comments
Apple fans may be miffed about the supply chain delays hitting the much-anticipated new iPhone X, but Apple investors don’t have much to worry about, according to a Wall Street analyst. “It’s certainly better than the alternative,” meaning lower demand, Andy Hargreaves, an analyst at KeyBanc, told CNBC’s Power Lunch on Friday. Pre-orders for Apple’s
0 Comments
Wall Street analysts are a bit confused by pharmacy CVS Health‘s possible purchase of health insurance provider Aetna, the largest proposed deal ever for the insurance industry. Calling the idea “insane,” Jefferies health-care desk analyst Jared Holz said CVS’ move to acquire Aetna came much sooner than he expected. “My view is [that there is]
0 Comments
The news roiled pharmaceutical stocks, while Amazon shares are at all-time highs. According to Tanquilut, Amazon’s business-to-business medical device web page was posted during the same period the company was granted wholesale distribution licenses in several states. The licensure was first reported by the St. Louis Post-Dispatch. An Amazon spokesperson previously told CNBC by email
0 Comments
Expedia CEO Mark Okerstrom told CNBC that the company’s stock decline on Friday is a “concern” but he is still “incredibly optimistic” about the future of the business. Shares of the travel company fell Friday, one day after it reported quarterly earnings that failed to meet Wall Street’s expectations. The stock was down about 18
0 Comments
Big tech stocks are already having a record day on Wall Street. Amazon, Microsoft and Google parent Alphabet all reported Q3 earnings after the bell Thursday, beating Wall Street expectations and sending stocks on the rise after hours and into the start of trading Friday. Amazon surged 11 percent, Microsoft spiked 9 percent, and Alphabet
0 Comments
Older Americans are frequent targets of financial scams in general, and about 12 percent are victims, according to the BBB’s Scam Tracker Annual Risk Report. While the rate of susceptibility among retirees is lower than in younger age groups, the per-scam loss amount tends to be higher. For instance, among the 65-and-older crowd in 2016,
0 Comments